Bristol-Myers Squibb Blood Cancer Drug Made in East Syracuse Wins FDA Approval
Tuesday, December 1, 2015
A new blood cancer drug made by Bristol-Myers Squibb at its East Syracuse plant has been approved by the Food and Drug Administration.
The FDA approved Empliciti to be used in combination with two other FDA-approved drugs to treat multiple myeloma, a blood cancer that kills more than 80,000 people annually.
The company also is making the drug at its plant in Puerto Rico.
"We are proud to bring patients a new type of therapy for previously treated multiple myeloma, an important step forward for a community bearing the weight of a devastating disease," Michael Giordano, a Bristol-Myers Squibb senior vice president, said in a prepared statement.